AiON

Self-harm

A population-based study in Ontario of men aged 66 and over treated with finasteride for benign prostatic hyperplasia found a higher risk of self-harm during the first 18 months of treatment (HR 1.88), but not thereafter.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.